Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FAAH | O00519 | 8/20 | 0.40 |
| ▸ | MGLL | Q99685 | 3/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | PSMB8 | P28062 | 2/20 | 0.31 |
| ▸ | PSMB5 | P28074 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12092221 | 0.90 | ALDH1A1 (0.42) | FAAHMGLLALDH1A1LMNAPSMB8 | |
| SCHEMBL17256338 | 0.88 | ALDH1A1 (0.49) | FAAHMGLLALDH1A1LMNA | |
| SCHEMBL3413319 | 0.87 | ALDH1A1 (0.51) | FAAHMGLLALDH1A1LMNA | |
| SCHEMBL12092220 | 0.84 | FAAH (0.31) | FAAHMGLL | |
| SCHEMBL10083912 | 0.84 | PSMB8 (0.32) | MGLLPSMB8PSMB5 | |
| SCHEMBL43576 | 0.82 | PSMB8 (0.35) | MGLLLMNAPSMB8PSMB5 | |
| SCHEMBL12921475 | 0.81 | MGLL (0.31) | MGLL | |
| SCHEMBL14516797 | 0.81 | MGLL (0.30) | MGLL | |
| SCHEMBL31522720 | 0.81 | PSMB8 (0.34) | MGLLLMNAPSMB8PSMB5 | |
| SCHEMBL18901605 | 0.80 | NPSR1 (0.33) | ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 42 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250340916-A1 | METHOD FOR SYNTHESIZING PEPTIDES IN CELL-FREE TRANSLATION SYSTEM | CHUGAI PHARMACEUTICAL CO LTD (JP) | 2025-11-06 | — | — | US | disclosed |
| US-12391971-B2 | Method for synthesizing peptides in cell-free translation system | CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) | 2025-08-19 | — | — | US | disclosed |
| CN-118256591-A | Cyclic peptide compound having high membrane permeability and library comprising same | 中外制药株式会社 | 2024-06-28 | — | — | CN | disclosed |
| CN-110869544-B | Cyclic peptide compound having high membrane permeability and library comprising same | 中外制药株式会社 | 2024-03-08 | — | — | CN | disclosed |
| US-20230046194-A1 | Ribosome-Mediated Incorporation of Peptides and Peptidomimetics | ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY (US) | 2023-02-16 | — | — | US | disclosed |
| US-20230046194-A1 | Ribosome-Mediated Incorporation of Peptides and Peptidomimetics | ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY (US) | 2023-02-16 | — | — | US | disclosed |
| US-20200370057-A1 | Ribosome-Mediated Incorporation of Peptides and Peptidomimetics | ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY (US) | 2020-11-26 | — | — | US | disclosed |
| US-20200370057-A1 | Ribosome-Mediated Incorporation of Peptides and Peptidomimetics | ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY (US) | 2020-11-26 | — | — | US | disclosed |
| US-10745705-B2 | Ribosome-mediated incorporation of peptides and peptidomimetics | ARIZON BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY (US) | 2020-08-18 | — | — | US | disclosed |
| US-10745705-B2 | Ribosome-mediated incorporation of peptides and peptidomimetics | ARIZON BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY (US) | 2020-08-18 | — | — | US | disclosed |
| EP-1911452-A1 | Silicon-derivates for PET-Imaging | Bayer Schering Pharma Aktiengesellschaft (DE) | 2008-04-16 | — | — | EP | disclosed |
| EP-1911452-A1 | Silicon-derivates for PET-Imaging | Bayer Schering Pharma Aktiengesellschaft (DE) | 2008-04-16 | — | — | EP | disclosed |
| WO-2008040441-A2 | SILICON DERIVATIVES FOR PET IMAGING | BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) | 2008-04-10 | — | — | WO | disclosed |
| WO-2008040441-A2 | SILICON DERIVATIVES FOR PET IMAGING | BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) | 2008-04-10 | — | — | WO | disclosed |
| EP-1908472-A1 | Silicon derivatives for PET imaging | Bayer Schering Pharma Aktiengesellschaft (DE) | 2008-04-09 | — | — | EP | disclosed |
| EP-1908472-A1 | Silicon derivatives for PET imaging | Bayer Schering Pharma Aktiengesellschaft (DE) | 2008-04-09 | — | — | EP | disclosed |
| US-20080039342-A1 | PROCESS FOR TRANSITION METAL-CATALYZED ELECTROCHEMICAL ALLYLIC ALKYLATION ON AN ELECTRODE ARRAY DEVICE | COMBIMATRIX CORPORATION (US) | 2008-02-14 | — | — | US | disclosed |
| US-20040146941-A1 | Chemical encoding technology for combinatorial synthesis | MASSACHUSETTS, UNIVERSITY OF | 2004-07-29 | — | — | US | disclosed |
| WO-2004041752-A2 | CHEMICAL ENCODING TECHNOLOGY FOR COMBINATORIAL SYNTHESIS | UNIVERSITY OF MASSACHUSETTS (US) | 2004-05-21 | — | — | WO | disclosed |
| WO-2003059926-A2 | METHODS AND COMPOSITIONS FOR AMINOACYL-tRNA SYNTHESIS | UNIVERSITY OF MASSACHUSETTS (US) | 2003-07-24 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200370057-A1 | Ribosome-Mediated Incorporation of Peptides and Peptidomimetics | NPEPPS, DNPEP, AARS1 | FAAH 4828/4885MGLL 4613/4885ALDH1A1 4835/4885 |
| US-20230046194-A1 | Ribosome-Mediated Incorporation of Peptides and Peptidomimetics | NPEPPS, DNPEP, AARS1 | FAAH 4828/4885MGLL 4613/4885ALDH1A1 4835/4885 |
| US-12391971-B2 | Method for synthesizing peptides in cell-free translation system | AARS1, NSUN3, RNGTT | FAAH 3433/4885MGLL 4420/4885ALDH1A1 4757/4885 |
| US-10745705-B2 | Ribosome-mediated incorporation of peptides and peptidomimetics | NPEPPS, DNPEP, AARS1 | FAAH 4828/4885MGLL 4613/4885ALDH1A1 4835/4885 |
| US-20250340916-A1 | METHOD FOR SYNTHESIZING PEPTIDES IN CELL-FREE TRANSLATION SYSTEM | AARS1, NSUN3, RNGTT | FAAH 3433/4885MGLL 4420/4885ALDH1A1 4757/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.